Page 9 - Five Prime News Today : Breaking News, Live Updates & Top Stories | Vimarsana

2 Min Read (Reuters) - Drugmaker Amgen Inc is buying Five Prime Therapeutics for about $1.9 billion to expand its line of gastric cancer drug candidates and its presence in Asia-Pacific, the companies said on Thursday. FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco, California October 21, 2013. REUTERS/Robert Galbraith Amgen has been looking to grow in the oncology market in the region since gaining a toehold in China in 2019 through a 20.5% stake in cancer drugmaker BeiGene Ltd for nearly $3 billion. It expects the region to contribute about a quarter of its...

Zai Lab Announces Financial Results for Second-half and Full-year 2020 March 01, 2021 07:00 ET | Source: Zai Lab Limited Zai Lab Limited -- Company to Host Conference Call and Webcast Today at 8:00 a.m. ET SHANGHAI and SAN FRANCISCO, March 01, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage biopharmaceutical company, today reported financial results for the second half and full year of 2020, along with corporate updates. “2020 was another year of great accomplishment for Zai Lab,” said Dr. Samantha Du, Founder,...

Data from the FIGHT trial suggests that approximately 30% of patients with non-human epidermal growth factor 2-positive GEJ cancers overexpress fibroblast growth factor receptor 2.

 E-Mail A phase 2 clinical trial providing personalized treatments based on the genetic profile of metastatic tumors in gastroesophageal cancers has found that using customized treatment approaches, and adapting them over time as tumors become resistant, led to higher rates of survival compared to historical controls. The final results were published online on Jan. 21 in Cancer Discovery, a journal of the American Association for Cancer Research. Advances in technology have made it possible for scientists and physicians to use information about the genetic makeup of a cancerous tumor to in...